Human-Relevant Preclinical Services​

NAMina Bio provides human-relevant preclinical services, from 3D drug screening in organoids and tumoroids to organ-on-chip studies, sequencing and bioinformatics, in silico modeling, AI-enabled hit discovery and medicinal chemistry. Services can be commissioned as single work packages, combined studies or NAMina-led translational programs.

​

Clients can work with us through advisory and study design, managed execution across our partner network, or technology implementation in their own laboratory. Many start with a feasibility consultation, a study design memo or a translational pilot. All services are provided for research use only.